OI
VRTX icon

Oakbrook Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Oakbrook Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,800
Closed -$1.32M – 627
2019
Q3 		$1.32M Buy
+7,800
New +$1.38M 0.09% 173
2019
Q1 		– Sell
-9,425
Closed -$1.56M – 645
2018
Q4 		$1.56M Sell
9,425
-7,675
-45% -$1.33M 0.11% 145
2018
Q3 		$3.3M Sell
17,100
-275
-2% -$49K 0.18% 90
2018
Q2 		$2.95M Sell
17,375
-645
-4% -$100K 0.19% 87
2018
Q1 		$2.94M Buy
18,020
+1,625
+10% +$265K 0.18% 89
2017
Q4 		$2.46M Sell
16,395
-4,380
-21% -$649K 0.16% 99
2017
Q3 		$3.16M Buy
20,775
+1,050
+5% +$158K 0.2% 89
2017
Q2 		$2.54M Buy
+19,725
New +$2.37M 0.17% 110
2016
Q2 		– Sell
-24,220
Closed -$1.93M – 593
2016
Q1 		$1.93M Buy
24,220
+10,000
+70% +$905K 0.12% 146
2015
Q4 		$1.79M Sell
14,220
-6,430
-31% -$776K 0.11% 155
2015
Q3 		$2.15M Buy
20,650
+350
+2% +$45K 0.14% 139
2015
Q2 		$2.51M Sell
20,300
-9,975
-33% -$1.26M 0.15% 136
2015
Q1 		$3.57M Buy
30,275
+12,275
+68% +$1.47M 0.19% 122
2014
Q4 		$2.14M Sell
18,000
-19,350
-52% -$2.18M 0.12% 167
2014
Q3 		$4.2M Sell
37,350
-27,203
-42% -$2.59M 0.23% 106
2014
Q2 		$6.11M Sell
64,553
-9,150
-12% -$642K 0.18% 135
2014
Q1 		$5.21M Sell
73,703
-7,950
-10% -$630K 0.16% 144
2013
Q4 		$6.07M Sell
81,653
-7,550
-8% -$526K 0.17% 141
2013
Q3 		$6.76M Buy
89,203
+67,250
+306% +$5.35M 0.2% 123
2013
Q2 		$1.76M Buy
+21,953
New +$1.62M 0.05% 302

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Oakbrook Investments's VRTX Position: Q4 2019 in Review

Oakbrook Investments sold out of Vertex Pharmaceuticals (VRTX) in Q4 2019, closing a stake of 7,800 shares — an estimated $1.32M sold.

Oakbrook Investments first reported a position in VRTX in Q2 2013 and held it in 20 quarters. The position peaked at $6.76M in Q3 2013. 814 funds tracked by Wall St. Rank hold VRTX as of Q4 2019.

  • Oakbrook Investments reported no remaining Vertex Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Oakbrook Investments sold 7,800 Vertex Pharmaceuticals shares in Q4 2019, an estimated $1.32M.
  • Oakbrook Investments first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • Oakbrook Investments's Vertex Pharmaceuticals position peaked at $6.76M in Q3 2013.
  • 814 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2019.

Based on Oakbrook Investments's 13F filing for Q4 2019, filed 6 Feb 2020.